{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:29:07Z","timestamp":1770910147166,"version":"3.50.1"},"reference-count":59,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Canine and feline fibrosarcomas are malignant tumors of mesenchymal origin showing histological, molecular, and clinical structures similar to their human equivalent. In human medicine, cellular myelocytomatosis (c-Myc) has already been proposed as a vital gene that regulates aggressive cell growth and is a predictive marker and possible therapeutic target in fibrosarcomas. The goal of this study was to evaluate c-Myc expression in canine and feline fibrosarcomas by gene and protein analyses and correlate its expression to the histological grading system of the examined cancers. Nineteen archival formalin-fixed and paraffin-embedded canine and feline sarcoma samples were recruited. Sixteen of them were determined to be canine and feline fibrosarcomas. The samples consisted of eight cutaneous samples, four eyelid samples, three oral mucosa samples, and one vulva sample. Histopathological examinations were performed to estimate histological type, differentiation, cellularity, and mitotic count. On each sample, immunohistochemical assessment and mRNA expression were performed using an anti-c-Myc antibody and a c-Myc primer. The differences in the immunoreactivity staining values and the relative folds of the c-Myc mRNAs were categorized using already recognized grading criteria and a statistical analysis was performed. Among all the tested canine and feline fibrosarcomas, 75% of the grade II fibrosarcoma cases and all of the grade III fibrosarcoma cases were positive for the c-Myc protein. Furthermore, the relative values of the c-Myc gene were up-regulated in grade III compare to grade I and II fibrosarcomas. The results demonstrated that c-Myc expression was significantly higher in grade III than in grade II and I (p \u2264 0.05) fibrosarcomas regarding protein and gene levels. In summary, this work provides evidence for the high expression of c-Myc in canine and feline fibrosarcomas and proposes a supposed relationship with poor prognoses as determined by grading systems.<\/jats:p>","DOI":"10.3390\/ani16040584","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:06:16Z","timestamp":1770905176000},"page":"584","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene Expression and Immunohistochemical Analyses of c-Myc in Canine and Feline Soft Tissue Fibrosarcomas"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-3074","authenticated-orcid":false,"given":"Waseem","family":"Al-Jameel","sequence":"first","affiliation":[{"name":"Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul 41002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Al-Saidya","sequence":"additional","affiliation":[{"name":"Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul 41002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baidaa","family":"Salah","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Education for Pure Science, University of Mosul, Mosul 41002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul 41002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-0354","authenticated-orcid":false,"given":"Saevan","family":"Al-Mahmood","sequence":"additional","affiliation":[{"name":"Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul 41002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vascellari, M., Baioni, E., Ru, G., Carminato, A., and Mutinelli, F. (2009). Animal tumor registry of two provinces in northern Italy: Incidence of spontaneous tumors in dogs and cats. BMC Vet. Res., 5.","DOI":"10.1186\/1746-6148-5-39"},{"key":"ref_2","unstructured":"Vegad, J.L. (2007). Neoplasia. A Text Book of Veterinary General Pathology, CBS Publication. [2nd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Meuten, D.J. (2002). Tumors of the Skin and Soft Tissues. Tumors in Domestic Animals, John Wiley & Sons. [4th ed.].","DOI":"10.1002\/9780470376928"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.20546\/ijcmas.2018.706.162","article-title":"Histopathological and Immunohistochemical Diagnosis of Canine Fibrosarcoma","volume":"7","author":"Subapriya","year":"2018","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jhered\/esi122","article-title":"Chromosome rearrangements in canine fibrosarcomas","volume":"96","author":"Sargan","year":"2005","journal-title":"J. Hered."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-3164.2011.00975.x","article-title":"Microchip-associated fibrosarcoma in a cat","volume":"22","author":"Carminato","year":"2011","journal-title":"Vet. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jfms.2007.05.002","article-title":"Bilateral subcutaneous fibrosarcomas in a cat following feline parvo-, herpes- and calicivirus vaccination","volume":"9","author":"Ducatelle","year":"2007","journal-title":"J. Feline Med. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-950X.1997.tb01497.x","article-title":"Surgical excision of soft tissue fibrosarcomas in cats","volume":"26","author":"Davidson","year":"1997","journal-title":"Vet. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1748-5827.2009.00809.x","article-title":"Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases","volume":"50","author":"Chase","year":"2009","journal-title":"J. Small Anim. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.9734\/acri\/2024\/v24i5755","article-title":"Pathomorphological and Immunohistochemical Study of Fibrosarcoma in an Adult Dog: A Case Report","volume":"24","author":"Saini","year":"2024","journal-title":"Arch. Curr. Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene\u2014The grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jso.2930540402","article-title":"c-myc oncogene expression: A marker for females at risk of carcinoma","volume":"54","author":"Hehir","year":"1993","journal-title":"J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/bjc.1993.350","article-title":"Over-expression of the c-myc proto-oncogene in colorectal carcinoma","volume":"68","author":"Smith","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12032-019-1317-6","article-title":"SOX4 is activated by C-MYC in prostate cancer","volume":"36","author":"Dong","year":"2019","journal-title":"Med. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3835(01)00501-8","article-title":"The correlation of TERT expression with c-myc expression in cervical cancer","volume":"168","author":"Sagawa","year":"2001","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/modpathol.2009.113","article-title":"Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma","volume":"22","author":"Tsiatis","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-018-0009-8","article-title":"Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma","volume":"6","author":"Chen","year":"2018","journal-title":"Bone Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajpath.2014.11.024","article-title":"Functional genomics analysis reveals a MYC signature associated with a poor clinical prognosis in liposarcomas","volume":"185","author":"Tran","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.3892\/mmr.2017.7101","article-title":"c-Myc promotes tumor proliferation and anti-apoptosis by repressing p21 in rhabdomyosarcomas","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/sj.onc.1202750","article-title":"The basic region\/helix-loop-helix\/leucine zipper domain of Myc proto-oncoproteins: Function and regulation","volume":"18","author":"Larsson","year":"1999","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1074\/jbc.RA118.002709","article-title":"Myc phosphorylation in its basic helix-loop-helix region destabilizes transient \u03b1-helical structures, disrupting Max and DNA binding","volume":"293","author":"Macek","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1677\/jme.1.02118","article-title":"Growth factor-dependent regulation of survivin by c-myc in human breast cancer","volume":"37","author":"Osgrave","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"ref_28","first-page":"219","article-title":"Immunohistochemical and Biochemical Expression Patterns of TTF-1, RAGE, GLUT-1 and SOX2 in HCV-Associated Hepatocellular Carcinomas","volume":"19","author":"Aboushousha","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_29","first-page":"38","article-title":"Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia","volume":"28","author":"Arafah","year":"2012","journal-title":"Turk Patoloji Derg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-013-2620-0","article-title":"Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response","volume":"140","author":"Lips","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/0377-4929.72000","article-title":"Immunohistochemical expression and correlation of mammaglobin with the grading system of breast carcinoma","volume":"53","author":"Rehman","year":"2010","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dobromylskyj, M. (2022). Feline Soft Tissue Sarcomas: A Review of the Classification and Histological Grading, with Comparison to Human and Canine. Animals, 12.","DOI":"10.3390\/ani12202736"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10354-016-0509-3","article-title":"Sclerosing epithelioid fibrosarcoma","volume":"167","author":"Patterson","year":"2017","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mikiewicz, M., Pa\u017adzior-Czapula, K., Fiedorowicz, J., Gesek, M., and Otrocka-Domaga\u0142a, I. (2023). Metallothionein expression in feline injection site fibrosarcomas. BMC Vet. Res., 19.","DOI":"10.1186\/s12917-023-03604-5"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1439-0442.2003.00544.x","article-title":"Fibrosarcomas at presumed sites of injection in dogs: Characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas","volume":"50","author":"Vascellari","year":"2003","journal-title":"J. Vet. Med. A Physiol. Pathol. Clin. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/mmr.2013.1774","article-title":"Expression and significance of Wnt signaling components and their target genes in breast carcinoma","volume":"9","author":"He","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/sj.bjc.6601703","article-title":"Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses","volume":"90","author":"Blancato","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/modpathol.2014.140","article-title":"Scoring of MYC protein expression in diffuse large B-cell lymphomas: Concordance rate among hematopathologists","volume":"28","author":"Mahmoud","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/bmm-2019-0073","article-title":"Plasma C-MYC level manifesting as an indicator in progression of breast cancer","volume":"13","author":"Shi","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.17582\/journal.pjz\/2017.49.6.2147.2152","article-title":"c-Myc has Altered Expression in Canine and Feline Tumors","volume":"49","author":"Manzoor","year":"2017","journal-title":"Pakistan J. Zool."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-021-01152-9","article-title":"Correction to: MYC: A multipurpose oncogene with prognostic and therapeutic implications in blood malignancies","volume":"14","author":"Ahmadi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, Metabolism, and Cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Scafuro, M., Capasso, L., Carafa, V., Altucci, L., and Nebbioso, A. (2021). Gene Transactivation and Transrepression in MYC-Driven Cancers. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073458"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kumari, A., Folk, W.P., and Sakamuro, D. (2017). The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance. Genes, 8.","DOI":"10.3390\/genes8060158"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbagrm.2014.07.004","article-title":"Impact of MYC in regulation of tumor cell metabolism","volume":"1849","author":"Henriksson","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1101\/gad.1024602","article-title":"c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression","volume":"16","author":"Baudino","year":"2002","journal-title":"Genes Dev."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sias, F., Zoroddu, S., Migheli, R., and Bagella, L. (2025). Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051973"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/030098587100800202","article-title":"Canine malignant mammary tumours","volume":"8","author":"Misdorp","year":"1971","journal-title":"I. Sarcomas. Vet. Pathol."},{"key":"ref_49","first-page":"38","article-title":"Retrospective review and systematic study of mammary tumors in dogs and characteristics of the extracellular matrix","volume":"9","author":"Tamaso","year":"2002","journal-title":"Braz. J. Vet. Res. Anim. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5829.2011.00272.x","article-title":"Outcome in dogs with surgically resected oral fibrosarcoma (1997\u20132008)","volume":"10","author":"Frazier","year":"2012","journal-title":"Vet. Comp. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2460\/javma.1994.204.04.610","article-title":"Histologically low-grade, yet biologically high-grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982\u20131991)","volume":"204","author":"Ciekot","year":"1994","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2460\/javma.2000.216.58","article-title":"Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986\u20131996)","volume":"216","author":"Hershey","year":"2000","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4161\/cc.5.12.2860","article-title":"MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E\/CDK2","volume":"5","author":"Karlsson","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-019-1187-z","article-title":"Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells","volume":"10","author":"Melnik","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ijgc-00009577-200111000-00006","article-title":"c-myc gene amplification detected in preinvasive intraepithelial cervical lesions","volume":"11","author":"Golijow","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/bjc.2016.46","article-title":"MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours","volume":"114","author":"Green","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/310592a0","article-title":"Expression of c-myc changes during differentiation of mouse erythroleukaemia cells","volume":"310","author":"Lachman","year":"1984","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/annonc\/mdn148","article-title":"Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma","volume":"19","author":"Scionti","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000421-199406000-00019","article-title":"Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification","volume":"17","author":"Barrios","year":"1994","journal-title":"Am. J. Clin. Oncol."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/4\/584\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:36:21Z","timestamp":1770906981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/4\/584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ani16040584"],"URL":"https:\/\/doi.org\/10.3390\/ani16040584","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}